Renovaro BioSciences and GEDi Cube Merger Under Scrutiny
Renowned short-seller Hindenburg Research has called out the merger between biopharmaceutical company Renovaro BioSciences and AI medical startup GEDi Cube, alleging inflated valuations and a history of controversy. Hindenburg’s report, titled “A Worthless AI Shell Game With A Murderous Magician Past,” highlights founder Serhat Gumrukcu’s past run-ins with the law and claims that the AI promises are overstated. The release of the report caused Renovaro’s shares to drop over 42%. Hindenburg Research had previously shorted Jack Dorsey’s Block and investigated the backing of the Tether stablecoin.
Renovaro BioSciences and GEDi Cube Merger Announcement
The same day that Renovaro announced its acquisition of GEDi Cube, Hindenburg Research released its report. The report questions GEDi Cube’s self-assessed valuation of $225 million and disputes its claimed relationship with computer hardware company NVIDIA. GEDi Cube, now RenovaroCube, focuses on early cancer detection using AI technology. The report also accuses Renovaro of enlisting stock promoters to hype up the merger deal.
Gumrukcu’s Legal Troubles and Past
Hindenburg Research’s report brings attention to Gumrukcu’s legal troubles in Turkey and the United States. In May 2022, he was arrested for involvement in a murder-for-hire plot. The report also alleges that his medical certifications were fabricated. Gumrukcu’s past as a magician in Turkey is highlighted, with recordings of his performances found by Hindenburg Research.
Hindenburg Research’s Claims about Renovaro Leadership
In its report, Hindenburg Research claims that Renovaro BioSciences leadership was aware of Gumrukcu’s past criminal activities. The report refers to Gumrukcu as a “magician” and questions the company’s rebranding from Enochian BioSciences to Renovaro BioSciences. Despite Gumrukcu’s arrest, he and his husband remain the largest shareholders of Renovaro.
Hot Take: Controversy Surrounding Renovaro BioSciences and GEDi Cube Merger
The merger between Renovaro BioSciences and GEDi Cube has come under scrutiny following a report by Hindenburg Research. The report alleges inflated valuations, overstated AI promises, and highlights the legal troubles of Renovaro’s founder, Serhat Gumrukcu. Renovaro’s shares dropped significantly in response to the report. The report also questions GEDi Cube’s valuation and its claimed partnership with NVIDIA. Hindenburg Research accuses Renovaro of enlisting stock promoters to hype up the merger deal. Additionally, the report brings attention to Gumrukcu’s past as a magician and his involvement in a murder-for-hire plot. Despite these controversies, Gumrukcu and his husband remain major shareholders of Renovaro.
By
By